{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:32:22Z","timestamp":1740130342981,"version":"3.37.3"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Shanghai Jiao Tong University medical-engineering interdisciplinary","award":["YG2017QN69"],"award-info":[{"award-number":["YG2017QN69"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Ewing sarcoma is a malignant bone tumor mainly affecting teenagers and young adults. Its main driver mutation, the EWS-FLI1 fusion gene, has been identified more than 20 years ago, whereas its other somatic mutations have been just recently reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we organized the somatic mutations from 216 Ewing sarcoma cases into 216 individual protein\u2013protein interaction networks by using interactome information. These mutation networks were then classified into five different clusters based on their structural similarities. The prognostic effect of mutation genes was evaluated according to their network features.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The cases in cluster two exhibited remarkably high metastasis and mortality rates, and STAG2, TP53 and TTN were the three most significantly mutated genes in this cluster. Microarray data demonstrate that the expression of STAG2, TP53 and TTN are down-regulated in the EWS-FLI1-knockdown Ewing sarcoma cells. However, the mutation effect analysis shows that the somatic mutations in TTN are less damaging than those in STAG2 and TP53. The analyses of functional network modules further revealed that STAG2, TP53 and their interacting gene partners participate in the oncogenic-related biological modules such as cell cycle and regulation of transcription from RNA polymerase II promoter while TTN, TP53 and their interacting gene partners constitute the modules less relevant to oncogenesis. The results of Gene Ontology analyses demonstrated that the uniquely mutated genes associated with poor prognosis in Clusters 1, 4 and 5 were distinctively enriched in epidermal growth factor-related functions and phosphoproteins.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study identified the highly lethal mutation combination cases and characterized the possible prognostic genes in Ewing sarcoma from a network perceptive.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jjco\/hyz037","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T12:38:28Z","timestamp":1551271108000},"page":"604-613","source":"Crossref","is-referenced-by-count":1,"title":["The prognostic signature of the somatic mutations in Ewing sarcoma: from a network view"],"prefix":"10.1093","volume":"49","author":[{"given":"Yuehui","family":"Zhang","sequence":"first","affiliation":[{"name":"Spine Center, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Song","sequence":"additional","affiliation":[{"name":"Spine Center, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qili","family":"Shi","sequence":"additional","affiliation":[{"name":"Stem Cell and Regenerative Medicine Laboratory, Ningbo No. 2 Hospital, Ningbo, Zhejiang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xupu","family":"Song","sequence":"additional","affiliation":[{"name":"Institute of Higher Education, Shanghai University of Finance & Economics, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libing","family":"Shen","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqi","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Public health, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Shao","sequence":"additional","affiliation":[{"name":"Spine Center, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"key":"2019070310230160500_hyz037C1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-011110-130237","article-title":"Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets","volume":"7","author":"Lessnick","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"2019070310230160500_hyz037C2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-5223(19)33852-8","article-title":"Medical tumors of the chest wall. Solitary plasmacytoma and Ewing\u2019s sarcoma","volume":"105","author":"Burt","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2019070310230160500_hyz037C3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ng0294-146","article-title":"A second Ewing\u2019s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG","volume":"6","author":"Sorensen","year":"1994","journal-title":"Nat Genet"},{"key":"2019070310230160500_hyz037C4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/359162a0","article-title":"Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours","volume":"359","author":"Delattre","year":"1992","journal-title":"Nature"},{"key":"2019070310230160500_hyz037C5","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","article-title":"The genomic landscape of pediatric Ewing sarcoma","volume":"4","author":"Crompton","year":"2014","journal-title":"Cancer Discov"},{"key":"2019070310230160500_hyz037C6","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","article-title":"Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations","volume":"4","author":"Tirode","year":"2014","journal-title":"Cancer Discov"},{"key":"2019070310230160500_hyz037C7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1200\/JCO.2005.02.081","article-title":"Ewing sarcomas with p53 mutation or p16\/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse","volume":"23","author":"Huang","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019070310230160500_hyz037C8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrg1272","article-title":"Network biology: understanding the cell\u2019s functional organization","volume":"5","author":"Barabasi","year":"2004","journal-title":"Nat Rev Genet"},{"key":"2019070310230160500_hyz037C9","doi-asserted-by":"crossref","first-page":"bau015","DOI":"10.1093\/database\/bau015","article-title":"NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes","volume":"2014","author":"An","year":"2014","journal-title":"Database"},{"key":"2019070310230160500_hyz037C10","doi-asserted-by":"crossref","first-page":"D970","DOI":"10.1093\/nar\/gks937","article-title":"TSGene: a web resource for tumor suppressor genes","volume":"41","author":"Zhao","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2019070310230160500_hyz037C11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nmeth.2561","article-title":"mentha: a resource for browsing integrated protein-interaction networks","volume":"10","author":"Calderone","year":"2013","journal-title":"Nat Methods"},{"key":"2019070310230160500_hyz037C12","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780199206650.001.0001","volume-title":"Networks: an introduction","author":"Newman","year":"2010"},{"key":"2019070310230160500_hyz037C13","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"2019070310230160500_hyz037C14","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1093\/bioinformatics\/bti551","article-title":"BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks","volume":"21","author":"Maere","year":"2005","journal-title":"Bioinformatics"},{"key":"2019070310230160500_hyz037C15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"2019070310230160500_hyz037C16","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1101\/gr.151340.112","article-title":"Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer","volume":"23","author":"Bilke","year":"2013","journal-title":"Genome Res"},{"key":"2019070310230160500_hyz037C17","first-page":"1","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","author":"Adzhubei","year":"2013","journal-title":"Curr Protoc Hum Genet"},{"key":"2019070310230160500_hyz037C18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"2019070310230160500_hyz037C19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","article-title":"Review of epidermal growth factor receptor biology","volume":"59","author":"Herbst","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019070310230160500_hyz037C20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"2019070310230160500_hyz037C21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.maturitas.2008.11.010","article-title":"Oncogenic pathways in hereditary and sporadic breast cancer","volume":"61","author":"Kenemans","year":"2008","journal-title":"Maturitas"},{"key":"2019070310230160500_hyz037C22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"key":"2019070310230160500_hyz037C23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"2019070310230160500_hyz037C24","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1056\/NEJMp078126","article-title":"Pluripotency redux\u2014advances in stem-cell research","volume":"357","author":"Gearhart","year":"2007","journal-title":"N Engl J Med"},{"key":"2019070310230160500_hyz037C25","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/cdd.2015.53","article-title":"TP53: an oncogene in disguise","volume":"22","author":"Soussi","year":"2015","journal-title":"Cell Death Differ"},{"key":"2019070310230160500_hyz037C26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"2019070310230160500_hyz037C27","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.4161\/cbt.4.12.2287","article-title":"Assessment of Epidermal Growth Factor Receptor (EGFR) signaling in paired colorectal cancer and normal colon tissue samples using computer-aided immunohistochemical analysis","volume":"4","author":"Messersmith","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"2019070310230160500_hyz037C28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1158\/0008-5472.226.65.1","article-title":"Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer","volume":"65","author":"Amann","year":"2005","journal-title":"Cancer Res"},{"key":"2019070310230160500_hyz037C29","doi-asserted-by":"crossref","first-page":"9885","DOI":"10.18632\/oncotarget.14241","article-title":"Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer","volume":"8","author":"Kozlova","year":"2017","journal-title":"Oncotarget"},{"key":"2019070310230160500_hyz037C30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"2019070310230160500_hyz037C31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"2019070310230160500_hyz037C32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting cancer with small molecule kinase inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat Rev Cancer"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/49\/7\/604\/28900423\/hyz037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T18:25:15Z","timestamp":1663007115000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/49\/7\/604\/5423808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,3,30]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyz037","relation":{},"ISSN":["1465-3621"],"issn-type":[{"type":"electronic","value":"1465-3621"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,3,30]]}}}